Poolbeg Pharma PLC
F:7JN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Poolbeg Pharma PLC
F:7JN
|
UK |
|
C
|
Clariant AG
XHAM:CLRN
|
CH |
|
U
|
Umicore SA
OTC:UMICF
|
BE |
|
Tryg A/S
OTC:TGVSF
|
DK |
|
Orsted A/S
CSE:ORSTED
|
DK |
|
Janus Henderson Group PLC
F:HDJ
|
UK |
|
T
|
Tyler Technologies Inc
SWB:TYP
|
US |
|
V2X Inc
F:1V1
|
US |
|
S
|
Smartone Telecommunications Holdings Ltd
XMUN:SMA
|
HK |
|
Acea SpA
MIL:ACE
|
IT |
|
S
|
Smartone Telecommunications Holdings Ltd
F:SMA
|
HK |
|
Mitek Systems Inc
NASDAQ:MITK
|
US |
|
A
|
Aeterna Zentaris Inc
NASDAQ:AEZS
|
US |
|
A
|
Acea SpA
XBER:DCA
|
IT |
|
Ryman Healthcare Ltd
ASX:RYM
|
NZ |
|
Ipsos SA
PAR:IPS
|
FR |
|
J
|
J Sainsbury PLC
F:SUY1
|
UK |
|
W
|
Worthington Industries Inc
F:WTH
|
US |
Wall St Price Targets
7JN Price Targets Summary
Poolbeg Pharma PLC
According to Wall Street analysts, the average 1-year price target for 7JN is 0.08 EUR with a low forecast of 0.08 EUR and a high forecast of 0.09 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7JN's stock price target?
Price Target
0.08
EUR
According to Wall Street analysts, the average 1-year price target for 7JN is 0.08 EUR with a low forecast of 0.08 EUR and a high forecast of 0.09 EUR.